What is there to say about Merck?
No there is curently no partnership
Yes Merck is providing Keytruda for free in a USCF sponsored combo trial
Yes a partnership hinges on positive combo trial results
New information: combination trial will have a patient size of 40-50 patients and will be statistically significant. Interim data to be expected at the earliest by Q4 and if all parties agree to releasing.
Also, they are working on a device that can go anywhere in the body to electroporate. This can have significant value at a later stage.
In my humble opinion, Oncosec is putting eveything in place to be a big winner. But, all will depent on positive combo trial results!
I feel comfortable holding my shares to await the results. If it gets manipulated down again, I will add.